Australia Deep Brain Stimulation Devices Market Size & Outlook
Australia deep brain stimulation devices market, 2018-2030 (US$M)
Related Markets
Australia deep brain stimulation devices market highlights
- The Australia deep brain stimulation devices market generated a revenue of USD 13.0 million in 2023 and is expected to reach USD 27.9 million by 2030.
- The Australia market is expected to grow at a CAGR of 11.5% from 2024 to 2030.
- In terms of segment, dual channel was the largest revenue generating product in 2023.
- Single Channel is the most lucrative product segment registering the fastest growth during the forecast period.
Deep brain stimulation devices market data book summary
| Market revenue in 2023 | USD 13.0 million |
| Market revenue in 2030 | USD 27.9 million |
| Growth rate | 11.5% (CAGR from 2023 to 2030) |
| Largest segment | Dual channel |
| Fastest growing segment | Single Channel |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Single Channel, Dual Channel |
| Key market players worldwide | Abbott Laboratories, Medtronic PLC, Boston Scientific Corp, Nexstim Oyj Registered Shs Reg S, LivaNova PLC, NeuroPace Inc |
Other key industry trends
- In terms of revenue, Australia accounted for 1.1% of the global deep brain stimulation devices market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, Japan deep brain stimulation devices market is projected to lead the regional market in terms of revenue in 2030.
- Thailand is the fastest growing regional market in Asia Pacific and is projected to reach USD 17.8 million by 2030.
Dual channel was the largest segment with a revenue share of 58.46% in 2023. Horizon Databook has segmented the Australia deep brain stimulation devices market based on single channel, dual channel covering the revenue growth of each sub-segment from 2018 to 2030.
Australia deep brain stimulation devices market is expected to grow at a higher CAGR over the forecast period owing to increase in the prevalence of neurological disorders such as dystonia, epilepsy, and PD.
Moreover, such nonprofit organizations are initiating awareness programs for neurological diseases such as PD. Thus, such initiatives being undertaken by both government and nonprofit organizations are expected to boost the growth of Australia deep brain stimulation devices market.
The utilization of deep brain stimulation devices for epilepsy-related seizures has recently been approved in Australia and other countries. For instance, Medtronic Deep Brain Stimulation System for Epilepsy was approved by the FDA in April 2018.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Deep Brain Stimulation Devices Market Scope
Deep Brain Stimulation Devices Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Australia deep brain stimulation devices market size, by product, 2018-2030 (US$M)
Australia Deep Brain Stimulation Devices Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
